Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Leukemia, Lymphoid × lucatumumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Leukemia, Lymphoid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

venetoclax 1 lucatumumab 1 ibrutinib 1 copanlisib 1 Rituximab 1 Dasatinib 1 CT-P10 1 Bendamustine Hydrochloride 1 Arsenic Trioxide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00108108 2012-10-01

Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy

Novartis

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Lymphoid, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡